Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03995706
Title Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors The University of Texas Health Science Center at San Antonio
Indications

breast cancer

glioblastoma

Therapies

Sacituzumab govitecan-hziy

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.